Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: Boehringer Ingelheim Limited Ellesfield Avenue Bracknell Berkshire RG12 8YS United Kingdom
An adjunct to oral anti-coagulation for prophylaxis of thrombo-embolism associated with prosthetic heart valves.
300-600 mg daily in three or four doses.
PERSANTIN is not recommended for children.
PERSANTIN should usually be taken before meals.
Due to the low number of observations, experience with dipyridamole overdose is limited. Symptoms such as a warm feeling, flushes, sweating, restlessness, feeling of weakness, dizziness and anginal complaints can be expected. A drop in blood pressure and tachycardia might be observed.
Symptomatic therapy is recommended. Administration of xanthine derivatives (e.g. aminophylline) may reverse the haemodynamic effects of dipyridamole overdose. Due to its wide distribution to tissues and its predominantly hepatic elimination, dipyridamole is not likely to be accessible to enhanced removal procedures.
5 years.
Do not store above 30°C. Protect from light.
Marketed packs: Blister pack containing 84 white sugar coated tablets
Non-marketed packs: Blister packs of 100 and 112 white sugar coated tablets.
None.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
